Authors:
Levin, ED
Damaj, MI
Glassco, W
May, EL
Martin, BR
Citation: Ed. Levin et al., Bridged nicotine, isonicotine, and norisonicotine effects on working memory performance of rats in the radial-arm maze, DRUG DEV R, 46(2), 1999, pp. 107-111
Citation: Jl. Wiley et Br. Martin, Effects of SR141716A on diazepam substitution for Delta(9)-tetrahydrocannabinol in rat drug discrimination, PHARM BIO B, 64(3), 1999, pp. 519-522
Authors:
Crocker, PJ
Saha, B
Ryan, WJ
Wiley, JL
Martin, BR
Ross, RA
Pertwee, RG
Razdan, RK
Citation: Pj. Crocker et al., Development of agonists, partial agonists and antagonists in the Delta(8)-tetrahydrocannabinol series, TETRAHEDRON, 55(49), 1999, pp. 13907-13926
Citation: Br. Martin et R. Johnston, Technology foresight for wiring up the national innovation system - Experiences in Britain, Australia, and New Zealand, TECHNOL FOR, 60(1), 1999, pp. 37-54
Authors:
Jarai, Z
Wagner, JA
Varga, K
Lake, KD
Compton, DR
Martin, BR
Zimmer, AM
Bonner, TI
Buckley, NE
Mezey, E
Razdan, RK
Zimmer, A
Kunos, G
Citation: Z. Jarai et al., Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors, P NAS US, 96(24), 1999, pp. 14136-14141
Authors:
Damaj, MI
Glassco, W
Aceto, MD
Martin, BR
Citation: Mi. Damaj et al., Antinociceptive and pharmacological effects of metanicotine, a selective nicotinic agonist, J PHARM EXP, 291(1), 1999, pp. 390-398
Authors:
Martin, BR
Jefferson, R
Winckler, R
Wiley, JL
Huffman, JW
Crocker, PJ
Saha, B
Razdan, RK
Citation: Br. Martin et al., Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists, J PHARM EXP, 290(3), 1999, pp. 1065-1079
Authors:
Damaj, MI
Slemmer, JE
Carroll, FI
Martin, BR
Citation: Mi. Damaj et al., Pharmacological characterization of nicotine's interaction with cocaine and cocaine analogs, J PHARM EXP, 289(3), 1999, pp. 1229-1236
Authors:
Ng, EW
Aung, MM
Abood, ME
Martin, BR
Razdan, RK
Citation: Ew. Ng et al., Unique analogues of anandamide: Arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas, J MED CHEM, 42(11), 1999, pp. 1975-1981
Authors:
Griffin, G
Wray, EJ
Tao, Q
McAllister, SD
Rorrer, WK
Aung, MM
Martin, BR
Abood, ME
Citation: G. Griffin et al., Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528:further evidence for cannabinoid CB2 receptor absence in the rat central nervous system, EUR J PHARM, 377(1), 1999, pp. 117-125
Citation: G. Griffin et al., Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum, BR J PHARM, 128(3), 1999, pp. 684-688
Authors:
Griffin, G
Wray, EJ
Rorrer, WK
Crocker, PJ
Ryan, WJ
Saha, B
Razdan, RK
Martin, BR
Abood, ME
Citation: G. Griffin et al., An investigation into the structural determinants of cannabinoid receptor ligand efficacy, BR J PHARM, 126(7), 1999, pp. 1575-1584
Citation: Jw. Huffman et al., Synthesis and pharmacology of the isomeric methylheptyl-Delta(8)-tetrahydrocannabinols, BIO MED CH, 6(12), 1998, pp. 2383-2396